AZATHIOPRINE
PURINE ANALOGUES · RHEUMATOID ARTHRITIS ·+1
ZYDUS PHARMACEU
Drug class
Purine Analogues
Purine analogues are a class of antimetabolite medications chemically structured to mimic endogenous purine nucleosides and bases, such as adenine and guanine. Read more about Purine Analogues
75 drugs in this class 47 manufacturers
Drugs in Purine Analogues
AZASAN (azathioprine)
PURINE ANALOGUES · RHEUMATOID ARTHRITIS ·+1
SALIX PHARMACEU
MERCAPTOPURINE
PURINE ANALOGUES · ACUTE LYMPHOID LEUKEMIA
Mylan Pharmaceuticals
FLUDARABINE PHOSPHATE
PURINE ANALOGUES · PROGRESSIVE CHRONIC LYMPHOCYTIC LEUKEMIA
MYLAN INSTITUTI
PURIXAN (mercaptopurine)
PURINE ANALOGUES · ACUTE LYMPHOID LEUKEMIA
NOVA LABORATORI
CLADRIBINE
PURINE ANALOGUES · HAIRY CELL LEUKEMIA
MYLAN INSTITUTI
MERCAPTOPURINE
PURINE ANALOGUES · ACUTE LYMPHOID LEUKEMIA
ROXANE/WEST-WAR
CLADRIBINE
PURINE ANALOGUES · HAIRY CELL LEUKEMIA
APP/FRESENIUS K
FLUDARABINE PHOSPHATE
PURINE ANALOGUES · PROGRESSIVE CHRONIC LYMPHOCYTIC LEUKEMIA
APP/FRESENIUS K
Filter & compare in the drug finder →
Opens the drug finder with Purine Analogues preselected. Add indication or manufacturer filters there.
Purine analogues are a class of antimetabolite medications chemically structured to mimic endogenous purine nucleosides and bases, such as adenine and guanine.
Once incorporated into target cells and metabolically activated, they disrupt cellular proliferation by competing with natural substrates, inhibiting key enzymes in purine biosynthesis and DNA replication, and causing DNA strand termination or damage.
Therapeutically, these agents are primarily indicated for the treatment of hematologic malignancies, including acute leukemias, chronic lymphocytic leukemia, and hairy cell leukemia, as well as selected autoimmune conditions like multiple sclerosis and inflammatory bowel disease.
-
fda.gov
Purine analogues are a class of antimetabolite medications chemically structured to mimic endogenous purine nucleosides and bases, such as adenine and guanine Once incorporated into target cells and metabolically activated, they disrupt cellular proliferation by competing with natural substrates, inhibiting key enzymes in purine biosynthesis and DNA replication, and causing DNA strand termination or damage
-
fda.gov
Purine analogues are a class of antimetabolite medications chemically structured to mimic endogenous purine nucleosides and bases, such as adenine and guanine Once incorporated into target cells and metabolically activated, they disrupt cellular proliferation by competing with natural substrates, inhibiting key enzymes in purine biosynthesis and DNA replication, and causing DNA strand termination or damage Therapeutically, these agents are primarily indicated for the treatment of hematologic mal...
-
fda.gov
Once incorporated into target cells and metabolically activated, they disrupt cellular proliferation by competing with natural substrates, inhibiting key enzymes in purine biosynthesis and DNA replication, and causing DNA strand termination or damage Therapeutically, these agents are primarily indicated for the treatment of hematologic malignancies, including acute leukemias, chronic lymphocytic leukemia, and hairy cell leukemia, as well as selected autoimmune conditions like multiple sclerosis ...
-
fda.gov
Therapeutically, these agents are primarily indicated for the treatment of hematologic malignancies, including acute leukemias, chronic lymphocytic leukemia, and hairy cell leukemia, as well as selected autoimmune conditions like multiple sclerosis and inflammatory bowel disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.